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Dynamic computed tomography to determine cardiac output in
patients with left ventricular assist devices
Subha V. Raman, MD, MSEE, Tam Tran, BS, Orlando P. Simonetti, PhD, and Benjamin Sun, MD
Objective: The purpose of this study was to develop and test a novel, noninvasive means of estimating cardiac
output in patients with continuous-flow left ventricular assist devices.
Methods: Based on the indicator dilution principle, we estimated cardiac output from signal intensity versus time
recordings during first-pass imaging with contrast-enhanced computed tomography. To account for recirculation,
a gamma variate function was modified to model the indicator concentration curve. A proportionality constant for
64-slice computed tomography data acquisition was derived relating computed tomography Hounsfield units to
indicator concentration. Validity of the equation was tested in ambulatory patients with continuous-flow left ven-
tricular assist devices who underwent simultaneous computed tomography and Swan-Ganz catheter thermodilu-
tion-based measurement of cardiac output at various left ventricular assist device rpm settings. Agreement
between measurements was testing using kappa statistic.
Results: Pairwise comparison of calculated output using the dynamic computed tomography test bolus technique
versus thermodilution output measurements yielded good agreement (P ¼ .03). The output calculated using dy-
namic computed tomography underestimated the thermodilution output measurement by 0.54  0.37 L/min
(95% confidence interval, 0.66–0.94).
Conclusions: Noninvasive estimation of cardiac output from left ventricular assist devices is feasible using first-
pass dynamic computed tomography. By affording simultaneous good visualization of the device in situ, com-
puted tomography may be useful for noninvasive assessment of location and function of ambulatory patients
with left ventricular assist devices.
Raman et al Cardiopulmonary SupportEach year, heart failure results in 250,000 deaths in the
United States, and limited availability of donor hearts makes
cardiac transplantation a viable option for only a fraction of
end-stage heart failure patients. In this setting, ventricular as-
sist devices (VADs) provide a bridge to transplantation or
act simply as destination therapy without subsequent trans-
plantation.1-3 The typical VAD configuration for left heart
support places (1) the rotor device in the left peritoneal cav-
ity, (2) an input cannula in the left ventricular apex, and (3)
an output cannula sewn into the ascending aorta. By either
pulsatile or continuous flow, VADs generate the cardiac out-
put needed for end-organ perfusion.
Cardiac output may rely entirely on the VAD in the setting
of end-stage heart failure or may be a combination of resid-
ual native heart function and VAD output. The internal flow
estimator of axial flow (one of the continuous flow) LVADs
is neither consistently nor reliably accurate. A noninvasive
assessment of cardiac output could help guide adjustment
and potential weaning of VAD support in patients, particu-
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artifact may limit ultrasound-based measurements, and mul-
tiple device components preclude interrogation with mag-
netic resonance. Mahnken and colleagues4,5 have shown
that dynamic computed tomography (CT) could provide ac-
curate assessment of cardiac output using the concept of in-
dicator dilution applied to noninvasive tracking of iodinated
contrast. We sought to extend this work to measure cardiac
output in response to variable VAD output.
METHODS
Cardiac Output Model
Cardiac output can be calculated from the time enhancement curve based
on the Stewart-Hamilton equation:
CO ¼ QRN
0
cðtÞdt;
where CO is cardiac output and Q is the amount of contrast used in milli-
grams. Using 20 mL of iodinated contrast agent with a density of 350 mg/
mL yielded a Q value of 7000 mg of iodine. The function c(t) is the indi-
cator concentration. To account for recirculation, a gamma variate function
is used to model the indicator concentration curve, an excellent model of the
first pass of fluids through the cardiovascular system.6 Mahnken and col-
leagues4 showed that the Stewart-Hamilton equation can be simplified to:
CO ¼ K  Q
A
;
whereA is the area under the indicator concentration curve andK is a propor-
tionality constant that converts c(t) from units of signal intensity (Houns-
field units) to units of concentration. The K value must be adjusted based
on the specific CT machine configuration and scan parameters.
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Determination of K Value
The CO ¼ K  QA equation can be arranged into K ¼ CO  AQ . The Q
value is known, and CO can be computed as left ventricular stroke volume
3 heart rate. The stroke volume is measured from contiguous short-axis
cine images covering the left ventricle by tracing end-systolic and end-
diastolic areas in each slice. Knowing the thickness of each slice, the end-
diastolic volume and end-systolic volume are computed using Simpson’s
rule: Stroke volume ¼ end-diastolic volumeend-systolic volume. A is cal-
culated by integration of the dynamic contrast enhancement signal acquired in
the ascending aorta. The data necessary to estimateK are routinely obtained in
patients undergoing coronary CT angiography using a test bolus for contrast
timing. Images from test bolus injections obtained in 23 patients undergoing
coronary CT angiography were used to determine the K value using the for-
mula above; the average K value over these patients was 13.6.
In vivo Validation Studies
Patients in heart failure with continuous-flow left heart VADs scheduled
for right heart catheterization were prospectively enrolled to undergo simul-
taneous right heart catheterization and dynamic CT. All patients provided
written informed consent to participate in this Institutional Review
Board–approved human subjects investigation. Right heart catheterization
was performed in all cases to quantify pulmonary hypertension and invasive
hemodynamics as part of pre–heart transplantation planning. Excluded from1214 The Journal of Thoracic and Cardiovascular Suenrollment were patients with allergy to iodinated contrast agent or signif-
icant renal insufficiency (glomerular filtration rate< 30 mL $ min1 $
m2). No patient had active thyroid disease or childbearing potential.
CT Protocol
Upon completion of cardiac catheterization, the fluid-filled end-hole
catheter was secured with the tip in a proximal branch pulmonary artery
(confirmed by fluoroscopy), and patients were transported in the supine po-
sition to the CT scanner (Somatom 64, SiemensMedical Solutions, Inc, For-
chheim, Germany). After scout images were obtained, a single axial slice
location in the ascending aorta distal to the anastomosis of the output can-
nula was selected (Figure 1). The protocol for cardiac output measurement
at different VAD settings was then as follows: first, an invasive cardiac out-
put measurement was obtained using thermodilution technique. Next, a 20
mL bolus of isosmolar contrast agent (Visipaque 350 GE Healthcare, Wau-
kesha, Wis) was injected followed by 20 mL of saline, both via peripheral
vein at a rate of 4 mL/s. During the injection, repeated single-slice imaging
was performed at the predetermined axial location with a temporal resolu-
tion of 750 ms, resulting in 40 to 50 images. This test bolus scan was ob-
tained using minimal radiation dose of 2 mSv. The VAD output (rpm)
was then increased or decreased, and after an equilibration period of 8 to
10 minutes, another test bolus scan was obtained. For each patient, a total
of 5 VAD output settings were queried in this fashion.
Image Analysis
The test bolus scan yields 40 images at the same axial location over time
(Figure 2), allowing a region of interest to be drawn in the distal ascending
aorta to derive a signal-intensity versus time curve. The data points were
exported as a text file allowing transfer to a PC for computation using the for-
mula derived above (MATLABsoftware,TheMathworks, Inc,Natick,Mass).FIGURE 1. A, Volume rendering of computed tomography (CT) images demonstrates the position of the outflow cannula and aorta in a patient with a left
ventricular assist device. B, C, andD are axial CT images of the test bolus scan at serial time points after injection of contrast showing subsequent enhancement
of the superior vena cava (SVC),main pulmonary artery (MPA), and ascending aorta (AAo). The average signal intensity within a region of interest placed in
the AAo is 2, 24, and 128 Hounsfield units on these serial images.rgery c May 2009
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Comparison of calculated output using the dynamic CT test bolus
method to thermodilution output measured by invasive right heart catheter-
ization was performed using Wilcoxon signed-rank test of equality of pairs.
Evaluation of systematic bias between noninvasive and invasive measure-
ments was performed using Bland-Altman analysis.7,8
RESULTS
All 4 patients successfully completed the multiple test
bolus dynamic CT acquisition protocol. Image quality was
adequate for analysis in all acquisitions.
Table 1 summarizes the data collected from 4 patients and
multiple VAD rpm settings for each patient. Pairwise
FIGURE 2. The average signal intensity in a region of interest drawn on the
test bolus images in the distal ascending aorta versus time during injection of
a small bolus of contrast. The blue dots represent the raw data, and the dotted
pink line represents the gamma variate curve fit. HU, Hounsfield units.CO, Cardiac output; CI, cardiac index.
The Journal of Thoracic and Ccomparison of calculated output using the dynamic CT test
bolus technique versus thermodilution output measurements
yielded good agreement (Figure 3, A; P¼ .03). For 10 VAD
settings in the 4 patients, the readout of estimated cardiac
output on the device readout was recorded. This correlated
very poorly with invasive measurements (Figure 3, B).
The output calculated using dynamic CT tended to under-
estimate the thermodilution output measurement by 0.54 
0.37 L/min (95% confidence interval 0.66–0.94; Figure 4).
The 2 points that fell outside of the standard Bland-Altman
boundaries (1.96 standard deviation) involved 1 VAD set-
ting at 7200 rpm in a patient whose usual setting was 9000
rpm and another at a VAD setting of 9200 compared to usual
setting of 8200 with concomitant nonsustained ventricular
tachycardia during data acquisition.
DISCUSSION
We adapted the indicator dilution technique for noninva-
sive estimation of cardiac output and showed good agree-
ment with invasive measurements in patients with
continuous-flow left VADs. By tracking a contrast bolus
over time as previously developed for native heart cardiac
output, we have demonstrated feasibility of noninvasive car-
diac output measurement in patients with VADs.
This work highlighted several important aspects of left
VAD physiology. First, we acquired our CT measurements
in the ascending aorta distal to the outflow cannula insertion
site. The measured cardiac output, therefore, would reflect
the combination of left VAD output as well as any native
cardiac output. We used this location because it is this output
that is most relevant for end-organ perfusion, the ultimateC
PTABLE 1. Ventricular assist device settings and hemodynamic measurements
Patient No. RPM setting
Dynamic CT
CO (L/min)
Dynamic CT CI
(L $ min1 $ m2)
Thermodilution
CO (L/min)
Thermodilution
CI (L $ min1 $ m2)
1 10000 3.4 1.5 4.3 1.9
1 10400 3.8 1.6 4.6 2.0
1 10800 5.1 2.2 5.0 2.2
1 9000 3.7 1.6 4.0 1.7
2 9400 3.1 1.7 3.3 1.8
2 8000 3.7 2.0 4.0 2.2
2 7000 3.2 1.8 3.9 2.2
2 8000 3.0 1.7 3.3 1.8
2 9400 3.9 2.2 4.6 2.5
3 8200 4.0 2.4 4.5 2.7
3 9200 5.0 3.0 4.4 2.7
3 10400 3.8 2.3 4.4 2.7
3 8200 4.2 2.6 5.0 3.0
3 7200 2.9 1.8 4.4 2.7
4 9000 5.3 2.3 6.3 2.8
4 8000 4.6 2.0 4.7 2.1
4 9000 5.2 2.3 5.6 2.5
4 10000 5.4 2.4 6.3 2.8
4 9000 5.2 2.3 6.0 2.7ardiovascular Surgery c Volume 137, Number 5 1215
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catheter thermodilution shows good agreement, with correlation coefficient of 0.74. B, Linear regression between the device cardiac output readout and ther-
modilution measurement shows poor agreement, with correlation coefficient of 0.14.goal of VAD therapy. The acquisition plane could have been
placed more proximally such that both the outflow cannula
and aortic root proximal to the outflow cannula could be
seen in cross section, allowing generation of individual sig-
nal intensity–time curves for device and native heart. In this
manner, our noninvasive technique could be applied to fur-
ther study the relative contributions of left VAD function
and native heart function in various states of heart failure
and recovery. Second, we studied patients with continu-
ous-flow devices rather than pulsatile devices. The relative
physiologic merits of one output mechanism versus the other
continue to be debated, though most current devices tend to
use a continuous-flow model. Quantitative comparisons,
particularly using preclinical models, could be performed
serially using our technique. Third, the response to increases
and decreases in VAD rpm settings are nonlinear and also
afford insights into the optimal VAD settings in a given pa-
tient under various hemodynamic circumstances.
Echocardiography is the most widely used modality for
assessment of patients post-VAD placement.9,10 A host of
secondary findings, ranging from closure of the aortic valve
FIGURE 4. Bland-Altman plot shows the difference between the two car-
diac output (CO) measurement techniques versus the average value ob-
tained with the 2 techniques. The mean difference was 0.54 L/min, with
a 95% confidence interval difference of 0.66 to 0.94 L/min.1216 The Journal of Thoracic and Cardiovascular Suthroughout the cardiac cycle to absence of significant mitral
regurgitation, allow echo-based imaging to infer adequate
decompression of the left ventricle and appropriate VAD
functioning. However, severe acoustic shadowing may limit
visualization of cannula placement. CT overcomes these
limitations, and with the additional hemodynamic data that
may be provided based on the results of our work, this
modality may offer additional information regarding VAD
location and performance not readily obtained with echocar-
diography alone.
When performing procedures involving ionizing radia-
tion, dose should be minimized given uncertainty as to
long-term health effects at the albeit small radiation doses
used for diagnostic imaging. The minimal dose required
for the single timing bolus CT scan for cardiac output mea-
surement as described in this work pales in comparison to
the doses patients with VADs are typically exposed to
over the course of multiple invasive coronary angiograms,
nuclear viability studies, endomyocardial biopsy proce-
dures, and other sources of radiation. Furthermore, the theo-
retical lifetime risks must be weighed against the short-term
health care needs in this population, whose survival beyond
1 year may depend heavily on appropriate assist device func-
tioning. Additionally, the noninvasive volumetric visualiza-
tion of the device in situ afforded by CT is unique compared
with other diagnostic modalities and may be useful in cannu-
lae localization or in defining other positional contributors to
VAD output.
Examination of the contribution of backflow in the ascend-
ing aorta was not performed, as this component is likely in-
cluded in the net aortic flow measurement obtained with
our technique. This nongated acquisition over approximately
40 seconds includes multiple cardiac cycles, precluding as-
sessment of individual phasic changes in output. The type
of VAD and cannulation sites may also impact the results ob-
tained with this technique and warrant further study. Periph-
eral venous access has been cited as a potential limitation of
this technique.
The accuracy of the flow estimator on the HeartMate II
(Transonics Systems, Inc, Ithaca, NY) is quite variable,rgery c May 2009
Raman et al Cardiopulmonary Supportmotivating this work to obtain more accurate measures of
flow device–estimated cardiac output. Improved techniques
for serial flow assessment may help guide studies of heart
unloading and device output optimization.
In summary,we have shown that dynamicCTmay provide
accurate noninvasive estimates of cardiac output in patients
with continuous-flow left VADs. This approach may be use-
ful in addressing clinical questions regarding VAD function
as well as investigations regarding VAD physiology.
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